Total cases of PAH 1969
Subtypes of PAH, n (%)
Idiopathic PAH
1958 (99.4)
Heritable PAH
11 (0.6)
Sex, n (%)
Male
617 (31.3)
Female
1333 (67.7)
Not reported
19 (1.0)
Age, n (%)
0–19
218 (11.1)
20–39
403 (20.5)
40–59
409 (20.8)
60–79
735 (37.3)
>80
146 (7.4)
Not reported
58 (2.9)
Clinical outcomes reported in the JADER database, n (%)
Death from any causea
402 (20.4)
Non-deathb
1567 (79.6)
aThe clinical outcomes of the PAH patients with at least one adverse event that resulted in death were defined as death from any cause. bThe clinical outcomes of the PAH patients without adverse events that resulted in death were defined as non-death. PAH, pulmonary arterial hypertension; JADER, Japanese Adverse Drug Event Report. aThe clinical outcomes of the PAH patients with at least one adverse event that resulted in death were defined as death from any cause. bThe clinical outcomes of the PAH patients without adverse events that resulted in death were defined as non-death. PAH, pulmonary arterial hypertension; JADER, Japanese Adverse Drug Event Report.